Committee approves miscellaneous agriculture committee bill (draft 1.1) and clarifies 'beneficial substances' language

The Committee on Agriculture, Food Resiliency, & Forestry voted 8-0 to approve a miscellaneous agriculture committee bill (posted as DR25-0903 Draft 1.1) and to send the document to legislative drafting operations so it can receive a bill number and be referred to the appropriate committees.

Members flagged one sentence near the end of the bill’s long list of definitions that refers to “other chemical or biological substances beneficial to plants or their growing environment.” Committee members asked whether the language was intended to sweep in products such as biochar and whether those items are regulated as soil amendments or would fall under the umbrella “beneficial substances” language.

Discussion and clarifications - The committee did not change that particular language in the draft at the meeting. A staff explanation stated the clause is intended as an umbrella provision to avoid returning to the Legislature each time a novel product appears that technically does not fit existing defined terms.

- A committee member raised biochar specifically and asked whether it is regulated as a soil amendment; a staff member replied that biochar is regulated as a soil amendment and that several products are registered. The transcript did not list specific registration details.

Votes and process - Motion to approve the committee bill (DR25-0903 Draft 1.1) and recommend it for introduction: passed on roll call, 8 yes, 0 no, 0 abstain (yes: Representative Bosland; Rep. Burt; Rep. Linsky; Rep. Morgan; Rep. Nelson; Rep. O’Brien; Rep. Supernaught; Rep. Durfee). The chair instructed staff to provide a clean (non‑highlighted) copy to drafting operations and to the clerk.

Administrative directions - For committee bills, the chair must email legislative drafting operations with the approved document attached to obtain a bill number. The committee also assigned Representative Nelson as the committee’s reporter for the bill and asked staff to circulate a clean copy.

What the committee did not do - The meeting did not finalize regulatory definitions; members left the umbrella language in place and did not adopt new statutory definitions for “beneficial substance.” No final regulatory change was made at the meeting.

Next steps - The committee bill will be submitted to drafting operations for numbering, then referred to Appropriations and other relevant committees for consideration. Staff and the chair will circulate the clean copy of the approved draft to committee members and to drafting operations as directed.